This work demonstrates the synthesis of nonracemic tolterodine from azetidines, suggesting an efficient method for drug development.
A simple and atom‐economical protocol to access racemic and nonracemic γ , γ ‐diaryl/heteroaryl‐substituted propylamines in excellent yields (up to 98%) and with moderate enantiomeric excess (up to 62%) starting from azetidines and electron rich arenes/heteroarenes is described. The reaction involves Magic Blue‐initiated and incipient SbCl 5 ‐catalyzed S N 2‐type nucleophilic ring‐opening of activated azetidines with electron rich arenes/heteroarene under mild reaction conditions. The methodology has been efficiently used for the formal synthesis of optically active Tolterodine, an antimuscarinic drug.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: